207 related articles for article (PubMed ID: 26582807)
1. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
Willemse SB; Razavi-Shearer D; Zuure FR; Veldhuijzen IK; Croes EA; van der Meer AJ; van Santen DK; de Vree JM; de Knegt RJ; Zaaijer HL; Reesink HW; Prins M; Razavi H
Neth J Med; 2015 Nov; 73(9):417-31. PubMed ID: 26582807
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
[TBL] [Abstract][Full Text] [Related]
3. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
[TBL] [Abstract][Full Text] [Related]
4. Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
Gane E; Stedman C; Brunton C; Radke S; Henderson C; Estes C; Razavi H
N Z Med J; 2014 Dec; 127(1407):61-74. PubMed ID: 25530333
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C in the Czech Republic: Forecasting the disease burden.
Fraňková S; Urbánek P; Husa P; Němeček V; Razavi H; Razavi-Shearer D; Chlíbek R; Šperl J
Cent Eur J Public Health; 2019 Jun; 27(2):93-98. PubMed ID: 31241282
[TBL] [Abstract][Full Text] [Related]
6. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz ML; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus AL; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C
J Viral Hepat; 2014 May; 21 Suppl 1():34-59. PubMed ID: 24713005
[TBL] [Abstract][Full Text] [Related]
7. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
Wasitthankasem R; Vichaiwattana P; Siripon N; Posuwan N; Auphimai C; Klinfueng S; Thanetkongtong N; Vuthitanachot V; Saiyatha S; Thongmai C; Sochoo S; Pongsuwan N; Poovorawan K; Tangkijvanich P; Poovorawan Y
PLoS One; 2018; 13(4):e0196301. PubMed ID: 29689073
[TBL] [Abstract][Full Text] [Related]
8. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.
Rusch U; Robbins S; Razavi H; Vernazza P; Blach S; Bruggmann P; Müllhaupt B; Negro F; Semela D
Swiss Med Wkly; 2019 Jan; 149():w14694. PubMed ID: 30673118
[TBL] [Abstract][Full Text] [Related]
9. The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
Cousien A; Leclerc P; Morissette C; Bruneau J; Roy É; Tran VC; Yazdanpanah Y; Cox J
BMC Infect Dis; 2017 Feb; 17(1):162. PubMed ID: 28222681
[TBL] [Abstract][Full Text] [Related]
10. Estimates on HCV disease burden worldwide - filling the gaps.
Wedemeyer H; Dore GJ; Ward JW
J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
[TBL] [Abstract][Full Text] [Related]
11. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.
Hatzakis A; Chulanov V; Gadano AC; Bergin C; Ben-Ari Z; Mossong J; Schréter I; Baatarkhuu O; Acharya S; Aho I; Anand AC; Andersson MI; Arendt V; Arkkila P; Barclay K; Bessone F; Blach S; Blokhina N; Brunton CR; Choudhuri G; Cisneros L; Croes EA; Dahgwahdorj YA; Dalgard O; Daruich JR; Dashdorj NR; Davaadorj D; de Knegt RJ; de Vree M; Estes C; Flisiak R; Gane E; Gower E; Halota W; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kershenobich D; Kostrzewska K; Kristian P; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Norris S; Nurmukhametova E; Nymadawa P; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prabdial-Sing N; Prins M; Radke S; Rakhmanova A; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanchez Avila JF; Sanduijav R; Saraswat V; Seguin-Devaux C; Shah SR; Shestakova I; Shevaldin A; Shibolet O; Silva MO; Sokolov S; Sonderup M; Souliotis K; Spearman CW; Staub T; Stedman C; Strebkova EA; Struck D; Sypsa V; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuckerman E; Zuure FR; Puri P; Razavi H
J Viral Hepat; 2015 Jan; 22 Suppl 1():26-45. PubMed ID: 25560840
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).
Dore GJ; Ward J; Thursz M
J Viral Hepat; 2014 May; 21 Suppl 1():1-4. PubMed ID: 24713003
[TBL] [Abstract][Full Text] [Related]
13. Strategies to manage hepatitis C virus (HCV) disease burden.
Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz ML; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus AL; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E
J Viral Hepat; 2014 May; 21 Suppl 1():60-89. PubMed ID: 24713006
[TBL] [Abstract][Full Text] [Related]
14. Forecasting the disease burden of chronic hepatitis C virus in Poland.
Flisiak R; Halota W; Tomasiewicz K; Kostrzewska K; Razavi HA; Gower EE
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):70-6. PubMed ID: 25426979
[TBL] [Abstract][Full Text] [Related]
15. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
[TBL] [Abstract][Full Text] [Related]
16. Current and future health and economic impact of hepatitis C in Belgium.
Vandijck D; Moreno C; Stärkel P; Van Damme P; Van Vlierberghe H; Hindman SJ; Razavi H; Laleman W
Acta Gastroenterol Belg; 2014 Jun; 77(2):285-90. PubMed ID: 25090835
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.
Aljumah AA; Abaalkhail F; Al-Ashgar H; Assiri A; Babatin M; Al Faleh F; Alghamdi A; Al-Hakeem R; Hashim A; Alqutub A; Razavi H; Sanai FM; Al-Swat K; Schmelzer J; Altraif I
Saudi J Gastroenterol; 2016; 22(4):269-81. PubMed ID: 27488321
[TBL] [Abstract][Full Text] [Related]
18. Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.
Gane E; Kershenobich D; Seguin-Devaux C; Kristian P; Aho I; Dalgard O; Shestakova I; Nymadawa P; Blach S; Acharya S; Anand AC; Andersson MI; Arendt V; Arkkila P; Baatarkhuu O; Barclay K; Ben-Ari Z; Bergin C; Bessone F; Blokhina N; Brunton CR; Choudhuri G; Chulanov V; Cisneros L; Croes EA; Dahgwahdorj YA; Daruich JR; Dashdorj NR; Davaadorj D; de Knegt RJ; de Vree M; Gadano AC; Gower E; Halota W; Hatzakis A; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kostrzewska K; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Mossong J; Norris S; Nurmukhametova E; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prins M; Puri P; Radke S; Rakhmanova A; Razavi H; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanchez Avila JF; Sanduijav R; Saraswat V; Schréter I; Shah SR; Shevaldin A; Shibolet O; Silva MO; Sokolov S; Sonderup M; Souliotis K; Spearman CW; Staub T; Stedman C; Strebkova EA; Struck D; Sypsa V; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuckerman E; Zuure FR; Prabdial-Sing N; Flisiak R; Estes C
J Viral Hepat; 2015 Jan; 22 Suppl 1():46-73. PubMed ID: 25560841
[TBL] [Abstract][Full Text] [Related]
19. Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis G; Razavi H; Hatzakis A
J Gastroenterol Hepatol; 2017 Feb; 32(2):466-472. PubMed ID: 27403912
[TBL] [Abstract][Full Text] [Related]
20. Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Litzroth A; Suin V; Wyndham-Thomas C; Quoilin S; Muyldermans G; Vanwolleghem T; Kabamba-Mukadi B; Verburgh V; Jacques M; Van Gucht S; Hutse V
BMC Public Health; 2019 Jan; 19(1):39. PubMed ID: 30621662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
